Inflammatory Diseases Biologics Market to Reach USD 157.31 Billion by 2033 as Targeted Immunology Therapies Redefine Long-Term Disease Control
According to DataM Intelligence, the global Inflammatory Diseases Biologics Market was valued at USD 99.06 billion in 2024 and is projected to reach USD 157.31 billion by 2033, expanding at a CAGR of 5.3% during the forecast period 2025-2033. https://mma.prnewswire.com/media/1858619/3573087/DataM_Intelligence_Logo.jpg This growth reflects a structural shift in the management of chronic inflammatory and autoimmune disorders. […]